The continuing saga of complement receptor type 3 (CR3)

J Clin Invest. 1996 Jul 1;98(1):1-2. doi: 10.1172/JCI118752.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cytotoxicity, Immunologic*
  • Humans
  • Killer Cells, Natural / immunology*
  • Macrophage-1 Antigen / immunology*
  • Neoplasms / drug therapy
  • Neutrophils / immunology*
  • Polysaccharides / immunology*
  • Polysaccharides / pharmacology

Substances

  • Macrophage-1 Antigen
  • Polysaccharides